|
Volumn 46, Issue 4, 2011, Pages 615-
|
Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BORTEZOMIB;
DEXAMETHASONE;
MELPHALAN;
RISTOCETIN;
VON WILLEBRAND FACTOR;
ADULT;
AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
BONE MARROW BIOPSY;
CASE REPORT;
CLINICAL FEATURE;
DRUG TOLERABILITY;
HEMATOMA;
HUMAN;
HUMAN TISSUE;
LETTER;
MALE;
MULTIPLE CYCLE TREATMENT;
MULTIPLE MYELOMA;
MYELOPROLIFERATIVE DISORDER;
PRIORITY JOURNAL;
STEM CELL MOBILIZATION;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
TREATMENT RESPONSE;
TRISOMY;
TRISOMY 11;
TRISOMY 15;
TRISOMY 3;
TRISOMY 7;
TRISOMY 9;
VON WILLEBRAND DISEASE;
HUMANS;
JANUS KINASE 2;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
REMISSION INDUCTION;
THROMBOCYTHEMIA, ESSENTIAL;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 79953684021
PISSN: 02683369
EISSN: 14765365
Source Type: Journal
DOI: 10.1038/bmt.2010.157 Document Type: Letter |
Times cited : (7)
|
References (0)
|